Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome
- PMID: 20136956
- DOI: 10.1111/j.1440-1746.2009.06034.x
Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome
Comment on
-
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.J Gastroenterol Hepatol. 2009 Nov;24(11):1791-7. doi: 10.1111/j.1440-1746.2009.05873.x. Epub 2009 Aug 3. J Gastroenterol Hepatol. 2009. PMID: 19686420 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
